Literature DB >> 344212

Chicken embryo model for type III group B beta-hemolytic streptococcal septicemia.

J Tieffenberg, L Vogel, R R Kretschmer, D Padnos, S P Gotoff.   

Abstract

A lethal septicemia was induced in 11- and 12-day-old chicken embryos with intravenous inoculation of relatively small numbers of a clinical isolate (GBBHS-III-Bell) or a reference strain (GBBHS-III-D136-C) of group B beta-hemolytic streptococci (GBBHS). GBBHS-III-Bell was more virulent than GBBHS-III-D136-C, and 11-day-old chicken embryos were more susceptible than 12-day-old chicken embryos. Type-specific rabbit antisera protected the embryos from bacterial challenge, and this protective effect was absorbed with homologous but not heterologous GBBHS strains. A heterologous antiserum and normal rabbit sera provided some protection, which could be absorbed with either homologous or heterologous GBBHS strains. The chicken embryo is a suitable animal model for the study of infection and immunity with GBBHS type III.

Entities:  

Mesh:

Year:  1978        PMID: 344212      PMCID: PMC414109          DOI: 10.1128/iai.19.2.481-485.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

Review 1.  Summary of the workshop on perinatal infections due to group B Streptococcus.

Authors: 
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

2.  Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci.

Authors:  R S Baltimore; D L Kasper; C J Baker; D K Goroff
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

3.  Transfer of immunoglobulins and antibodies in the hen's egg.

Authors:  T T Kramer; H C Cho
Journal:  Immunology       Date:  1970-07       Impact factor: 7.397

4.  Immunity to the group B streptococci: interaction of serum and macrophages with types Ia, Ib, and Ic.

Authors:  B F Anthony
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

5.  The chick embryo in studies of virulence and immunity with Neisseria Gonorrhoeae.

Authors:  B B Diena; G Lavergne; A Ryan; F E Ashton; R Wallace; M Perry; V Daoust
Journal:  Rev Can Biol       Date:  1975-12

6.  Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.

Authors:  C J Baker; D L Kasper
Journal:  N Engl J Med       Date:  1976-04-01       Impact factor: 91.245

7.  Pathogenesis and immunology of experimental gonococcal infection: virulence of colony types of Neisseria gonorrhoeae for chicken embryos.

Authors:  L R Bumgarner; R A Finkelstein
Journal:  Infect Immun       Date:  1973-12       Impact factor: 3.441

8.  Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence.

Authors:  V G Hemming; R T Hall; P G Rhodes; A O Shigeoka; H R Hill
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

9.  Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens.

Authors:  R C Lancefield; M McCarty; W N Everly
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

10.  Protection against group B meningococcal disease. I. Comparison of group-specific and type-specific protection in the chick embryo model.

Authors:  C E Frasch; L Parkes; R M McNelis; E C Gotschlich
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

View more
  23 in total

1.  Gonococcal color and opacity variants: virulence for chicken embryos.

Authors:  I E Salit; E C Gotschlich
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

2.  Expression of both M protein and hyaluronic acid capsule by group A streptococcal strains results in a high virulence for chicken embryos.

Authors:  K H Schmidt; E Günther; H S Courtney
Journal:  Med Microbiol Immunol       Date:  1996-02       Impact factor: 3.402

3.  Group B streptococcal type Ia sepsis in mice after intranasal inoculation and the effect of infection on lungs.

Authors:  D E Wennerstrom
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

4.  Immunological aspects of group B streptococcal infections.

Authors:  R R Kretschmer; S P Gotoff
Journal:  Infection       Date:  1978       Impact factor: 3.553

5.  Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci.

Authors:  M K Yeung; S J Mattingly
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

6.  Enzyme-linked immunosorbent assay for measurement of antibody to type III group B streptococci.

Authors:  R A Polin; S D Douglas; D L Kasper; C J Baker
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

7.  Properties of a hemolysin produced by group B streptococci.

Authors:  B A Marchlewicz; J L Duncan
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

8.  Functional characteristics of a modified immunoglobulin preparation for intravenous administration: summary of studies of opsonic and protective activity against group B streptococci.

Authors:  G W Fischer; S R Wilson; K W Hunter
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

9.  Type-specific capsular antigen is associated with virulence in late-onset group B Streptococcal type III disease.

Authors:  M E Klegerman; K M Boyer; C K Papierniak; L Levine; S P Gotoff
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

10.  Experimental vaginal colonization and mother-infant transmission of group B streptococci in rats.

Authors:  R J Ancona; P Ferrieri
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.